Tazarotene 0.015% Cream as a Potential Topical Agent for Management of Ichthyosis in Dorfman-Chanarin Syndrome

Acta Derm Venereol. 2019 Mar 1;99(3):345-346. doi: 10.2340/00015555-3087.
No abstract available

Keywords: Dorfman-Chanarin syndrome; ichthyosis; optical coherence tomography; tazarotene 0.015% cream.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Female
  • Humans
  • Ichthyosiform Erythroderma, Congenital / drug therapy*
  • Ichthyosiform Erythroderma, Congenital / physiopathology
  • Ichthyosis, Lamellar / drug therapy*
  • Ichthyosis, Lamellar / physiopathology
  • Keratolytic Agents / therapeutic use*
  • Lipid Metabolism, Inborn Errors / drug therapy*
  • Lipid Metabolism, Inborn Errors / physiopathology
  • Muscular Diseases / drug therapy*
  • Muscular Diseases / physiopathology
  • Nicotinic Acids / therapeutic use*
  • Skin Cream / therapeutic use
  • Tomography, Optical Coherence
  • Water Loss, Insensible

Substances

  • Keratolytic Agents
  • Nicotinic Acids
  • tazarotene

Supplementary concepts

  • Chanarin-Dorfman Syndrome